Dow Up 0.51% Nasdaq Up 0.24%

Advaxis, Inc. (ADXS)

-NasdaqCM
2.95 Down 0.04(1.34%) Nov 21, 3:59PM EST
Prev Close:2.99
Open:3.00
Bid:2.96 x 500
Ask:3.25 x 200
1y Target Est:11.67
Beta:2.43
Next Earnings Date:N/A
Day's Range:2.90 - 3.03
52wk Range:2.46 - 5.99
Volume:68,243
Avg Vol (3m):261,075
Market Cap:57.58M
P/E (ttm):N/A
EPS (ttm):-1.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADXS

Comparison

Symbol% ChgMkt Cap
ADXSDown 1.34%57.58M
BVTI 0.00%N/A
DNDN 0.00%19.69M
VICLDown 0.91%98.46M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):58.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Oct-14) :-1.20
Quarterly EPS Est (Oct-14) :-0.31
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advaxis, Inc., a clinical development stage biotechnology company, focuses on developing immunotherapies for cancer and infectious diseases. The company’s Lm -LLO immunotherapy platform technology stimulates the immune system to induce antige... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback